Audiologic Status of Children with Confirmed Cytomegalovirus Infection: a Case Series

Audiologic Status of Children with Confirmed Cytomegalovirus Infection: a Case Series

Background: Congenital cytomegalovirus (CMV) is the most common cause of non-genetic sensorineural hearing loss (SHNL) in children. Only about 10% to 15% of children with congenital CMV is a symptom, and most are not diagnosed at birth. Approximately 7% to 15% of clinically asymptomatic patients may develop complications later, including Sensorineural hearing loss, which is the most common sequelae in patients with clinically asymptomatic. In this study, the hearing status were investigated in children with confirmed CMV infection and newborn hearing screening (NHS) is reviewed to explore the history of hearing loss caused by CMV.


Methods: The medical records of 58 children diagnosed with CMV infection was confirmed in terms of clinical symptoms and signs of CMV infection. Status hearing evaluated by audiological test battery according to age.


Results: A total of 58 children (M: F = 32:26 patient, age of study: mean, 5.62 years, range, 1-10 years) serologically diagnosed with CMV infection (14 patients, 21.1%), or diagnosed through PCR of serum (5, 7.9%) and / or PCR from urine (19, 26.8%). Hearing loss was confirmed in 11 children (19.0%), being bilateral in 6 (54.5%), and unilateral in 5 (45.5%). Note that 7 out of 17 ears with hearing loss passed NHS and diagnosed only after a re-evaluation if CMV infection is identified.


Conclusion: Hearing loss is a serious complication of CMV infection in children. Our results highlight the importance of timely audiological evaluation in children with clinical symptoms of CMV infection even if they pass the NHS.

 Audiologic Status of Children with Confirmed Cytomegalovirus Infection: a Case Series
Audiologic Status of Children with Confirmed Cytomegalovirus Infection: a Case Series

Rare cases of Cytomegalovirus in Gut in immunocompetent hosts With Ischemic Colitis

Cytomegalovirus (CMV) infection is usually seen in individuals with immunosuppressive conditions such as malignancy, HIV / AIDS, and organ transplants, and in patients with chemotherapy or steroids. recurrent disease can occur if the reactivation of the virus because the immune disorder due to factors such as older age or immunosuppressive drugs. CMV is a common, with seroprevalence (CMV IgG) from 40-100% in adults, increases with age. It has been reported that inflammatory bowel disease in remission can be exacerbated by CMV complicate steroid refractory ulcerative colitis or flares. For this reason, steroids should be carefully initiated if a high clinical suspicion for CMV. We report a unique case of CMV colitis is associated with severe ischemic colitis in immunocompetent patients, with a very good response to management with antiviral therapy.


While the cytomegalovirus (CMV) reactivation occurs in critically ill immunocompetent patients and has been associated with worse outcomes, very few cases of CMV reactivation have been reported following the left ventricular assist device (LVAD) implantation. We aimed to evaluate the incidence and risk factors for CMV reactivation following LVAD implantation. A retrospective chart review of patients who have undergone LVAD implantation between July 2004 and December 2018 do. CMV reactivation cases with post-LVAD randomly matched (1: 2) by sex, type of LVAD, and the implant to control utilizing SAS macros.

Lenti-CDK4 Virus

LV611 10 ml
EUR 973.2

Lenti-hTERT virus

G200 10 ml
EUR 973.2

Rev-CEM-Luc HIV Reporter Cells

HRC-6 - Ask for price

AAV2-Luc Control Virus

AAV-320 50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 2.

AAV1-Luc Control Virus

AAV-321 50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 1.

AAV3-Luc Control Virus

AAV-323 50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 3.

AAV4-Luc Control Virus

AAV-324 50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 4.

AAV5-Luc Control Virus

AAV-325 50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 5.

AAV6-Luc Control Virus

AAV-326 50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 6.

Rev-A3R5-GFP/Luc HIV Reporter Cells

HRC-2 - Ask for price

Rev-CEM-GFP/Luc HIV Reporter Cells

HRC-5 - Ask for price

Lenti-hTERT Antisense virus

G201 10 ml
EUR 882

Lenti-hTERT-Neo Virus

G204 10 ml
EUR 973.2

Lenti-Myc T58A Virus

G217 10 ml
EUR 973.2

Lenti-p53 siRNA Virus

G219 10 ml
EUR 973.2

Lenti-Ras V12 Virus

G221 10 ml
EUR 973.2

Lenti-Rb siRNA Virus

G223 10 ml
EUR 973.2

Human Alpha-2-Microglobulin Like Protein 1 (a2ML1) ELISA Kit

DLR-a2ML1-Hu-48T 48T
EUR 574.8
Description: A sandwich quantitative ELISA assay kit for detection of Human Alpha-2-Microglobulin Like Protein 1 (a2ML1) in samples from serum, plasma, tissue homogenates or other biological fluids.

Human Alpha-2-Microglobulin Like Protein 1 (a2ML1) ELISA Kit

DLR-a2ML1-Hu-96T 96T
EUR 745.2
Description: A sandwich quantitative ELISA assay kit for detection of Human Alpha-2-Microglobulin Like Protein 1 (a2ML1) in samples from serum, plasma, tissue homogenates or other biological fluids.

Human Alpha-2-Microglobulin Like Protein 1 (a2ML1) ELISA Kit

RDR-a2ML1-Hu-48Tests 48 Tests
EUR 600

Human Alpha-2-Microglobulin Like Protein 1 (a2ML1) ELISA Kit

RDR-a2ML1-Hu-96Tests 96 Tests
EUR 830.4

Human Alpha-2-Microglobulin Like Protein 1 (a2ML1) ELISA Kit

RD-a2ML1-Hu-48Tests 48 Tests
EUR 573.6

Human Alpha-2-Microglobulin Like Protein 1 (a2ML1) ELISA Kit

RD-a2ML1-Hu-96Tests 96 Tests
EUR 794.4

Lenti-Bmi1 Virus, High Titer

LV608 5 x 20 ul
EUR 1825.2

Lenti-CDK4 Virus, High Titer

LV609 5 x 20 ul
EUR 1825.2

Lenti-hTERT Virus, High Titer

LV615 5 x 20 ul
EUR 1825.2

Lenti-EF1α-hTERT Virus

G706 10 ml
EUR 1094.4

Steady-Luc Firefly HTS Assay Kit (10x100 ml)

30028-3 1KIT
EUR 3774
Description: Minimum order quantity: 1 unit of 1KIT

Human BM88 Differentiation Reporter (pGreenZeo, Virus)

SR10021VA-1 >2 x 10^6 IFUs
EUR 906

Mouse Camk2a Differentiation Reporter (pGreenZeo, Virus)

SR10022VA-1 >2 x 10^6 IFUs
EUR 906

Mouse GAD67 Differentiation Reporter (pGreenZeo, Virus)

SR10023VA-1 >2 x 10^6 IFUs
EUR 906

Rat NSE Differentiation Reporter (pGreenZeo, Virus)

SR10024VA-1 >2 x 10^6 IFUs
EUR 906

Mouse MBP Differentiation Reporter (pGreenZeo, Virus)

SR10026VA-1 >2 x 10^6 IFUs
EUR 906

Human Opsin Differentiation Reporter (pGreenZeo, Virus)

SR10027VA-1 >2 x 10^6 IFUs
EUR 906

Human Insulin Differentiation Reporter (pGreenZeo, Virus)

SR10028VA-1 >2 x 10^6 IFUs
EUR 906

Human LCK Differentiation Reporter (pGreenZeo, Virus)

SR10032VA-1 >2 x 10^6 IFUs
EUR 906

Rat Nestin Differentiation Reporter (pGreenZeo, Virus)

SR10034VA-1 >2 x 10^6 IFUs
EUR 906

Human Nestin Differentiation Reporter (pGreenZeo, Virus)

SR10035VA-1 >2 x 10^6 IFUs
EUR 906

Mouse ALBP Differentiation Reporter (pGreenZeo, Virus)

SR10036VA-1 >2 x 10^6 IFUs
EUR 906

Human NGN3 Differentiation Reporter (pGreenZeo, Virus)

SR10037VA-1 >2 x 10^6 IFUs
EUR 906

Human PDX1 Differentiation Reporter (pGreenZeo, Virus)

SR10039VA-1 >2 x 10^6 IFUs
EUR 906

Human Osteocalcin Differentiation Reporter (pGreenZeo, Virus)

SR1003VA-1 >2 x 10^6 IFUs
EUR 906

Mouse PDX1 Differentiation Reporter (pGreenZeo, Virus)

SR10040VA-1 >2 x 10^6 IFUs
EUR 906

Human MAP2 Differentiation Reporter (pGreenZeo, Virus)

SR10047VA-1 >2 x 10^6 IFUs
EUR 906

Human FABP7 Differentiation Reporter (pGreenZeo, Virus)

SR10048VA-1 >2 x 10^6 IFUs
EUR 906

Human ACTC Differentiation Reporter (pGreenZeo, Virus)

SR10049VA-1 >2 x 10^6 IFUs
EUR 906

Human B29 Differentiation Reporter (pGreenZeo, Virus)

SR1004VA-1 >2 x 10^6 IFUs
EUR 906

Mouse Myogenin Differentiation Reporter (pGreenZeo, Virus)

SR10050VA-1 >2 x 10^6 IFUs
EUR 906

Human GFAP Differentiation Reporter (pRedZeo, Virus)

SR10051VA-1 >2 x 10^6 IFUs
EUR 906

Mouse B29 Differentiation Reporter (pGreenZeo, Virus)

SR1005VA-1 >2 x 10^6 IFUs
EUR 906

Human NKX2.5 Differentiation Reporter (pGreenZeo, virus)

SR10067VA-1 >2 x 10^6 IFUs
EUR 906

Mouse CD8 Differentiation Reporter (pGreenZeo, Virus)

SR1006VA-1 >2 x 10^6 IFUs
EUR 906

Mouse CD68 Differentiation Reporter (pGreenZeo, Virus)

SR1008VA-1 >2 x 10^6 IFUs
EUR 906

Human CD2 Differentiation Reporter (pGreenZeo, Virus)

SR1009VA-1 >2 x 10^6 IFUs
EUR 906

Oct4 CR4-pGreenFire Response Reporter (virus)

SR20070-VA-1 >2 x 10^6 IFUs
EUR 882

Mouse Actc Differentiation Reporter (pGreenZeo, Virus)

SR10010VA-1 >2 x 10^6 IFUs
EUR 906

Human Tnnt2 Differentiation Reporter (pGreenZeo, Virus)

SR10012VA-1 >2 x 10^6 IFUs
EUR 906

Mouse Tnnt2 Differentiation Reporter (pGreenZeo, Virus)

SR10013VA-1 >2 x 10^6 IFUs
EUR 906

Mouse SM22a Differentiation Reporter (pGreenZeo, Virus)

SR10014VA-1 >2 x 10^6 IFUs
EUR 906

Human GFAP Differentiation Reporter (pGreenZeo, Virus)

SR10015VA-1 >2 x 10^6 IFUs
EUR 906

Mouse GFAP Differentiation Reporter (pGreenZeo, Virus)

SR10016VA-1 >2 x 10^6 IFUs
EUR 906

Human CD11b Differentiation Reporter (pGreenZeo, Virus)

SR10017VA-1 >2 x 10^6 IFUs
EUR 906

Mouse EMR1 Differentiation Reporter (pGreenZeo, Virus)

SR10018VA-1 >2 x 10^6 IFUs
EUR 906

Mouse Col2a1 Differentiation Reporter (pGreenZeo, Virus)

SR1001VA-1 >2 x 10^6 IFUs
EUR 906

Mouse CD44 Differentiation Reporter (pGreenZeo, Virus)

SR10020VA-1 >2 x 10^6 IFUs
EUR 906

NF-kB/293/GFP-Luc Transcriptional Reporter Cell Line

TR860A-1 >2 x 10^6 cells
EUR 3915.6

Lenti-Myc T58A Virus, High Titer

LV618 5 x 20 ul
EUR 1825.2

Lenti-p53 siRNA Virus, High Titer

LV619 5 x 20 ul
EUR 1825.2

Lenti-Ras V12 Virus, High Titer

LV620 5 x 20 ul
EUR 1825.2

Lenti-Rb siRNA Virus, High Titer

LV621 5 x 20 ul
EUR 1825.2

Lenti-hTERT-Neo Virus, High Titer

LV622 5 x 20 ul
EUR 1825.2

Lenti-EF1α-hTERT-Hygro Virus

LV631 10 ml
EUR 1270.8

Lenti-HPV-16 E6/E7 Virus

G268 10 ml
EUR 882

Mouse Alpha-Tubulin Differentiation Reporter (pGreenZeo, Virus)

SR10025VA-1 >2 x 10^6 IFUs
EUR 906

Human SPP-1 Differentiation Reporter (pGreenZeo, Virus)

SR1002VA-1 >2 x 10^6 IFUs
EUR 906

Human Keratin 14 Differentiation Reporter (pGreenZeo, Virus)

SR10038VA-1 >2 x 10^6 IFUs
EUR 906

Human Doublecortin (DCX) Differentiation Reporter (pGreenZeo, Virus)

SR10041VA-1 >2 x 10^6 IFUs
EUR 906

Human HLA-DRa Differentiation Reporter (pGreenZeo, Virus)

SR1007VA-1 >2 x 10^6 IFUs
EUR 906

Human MLC-2v Differentiation Reporter (pGreenZeo, Virus)

SR10011VA-1 >2 x 10^6 IFUs
EUR 906

Human GFAP Differentiation Reporter (pGreenZeo, Virus) Puro

SR10015VA-P >2 x 10^6 IFUs
EUR 906

Mouse IBA-1 Differentiation Reporter (pGreenZeo, Virus)

SR10019VA-1 >2 x 10^6 IFUs
EUR 906

A2ML1 3'UTR Luciferase Stable Cell Line

TU000006 1.0 ml
EUR 1672.8

A2ML1 3'UTR GFP Stable Cell Line

TU050006 1.0 ml
EUR 1672.8

A2ML1 Antibody

1-CSB-PA001005LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against A2ML1. Recognizes A2ML1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200

A2ML1 Antibody

DF14404 100ul
EUR 420

anti-A2ML1

YF-PA22353 50 ul
EUR 435.6
Description: Mouse polyclonal to A2ML1

anti-A2ML1

YF-PA22354 50 ug
EUR 435.6
Description: Mouse polyclonal to A2ML1

Lenti-EF1α-hTERT Virus, High Titer

LV616 5 x 20 ul
EUR 2068.8

Lenti-CMV-hTERT-GFP-2A-Puro Virus

LV623 10 ml
EUR 1270.8

Lenti-CMV-hTERT-RFP-2A-Puro Virus

LV625 10 ml
EUR 1270.8

Human E-Cadherin, CDH1 Differentiation Reporter (pGreenZeo, virus)

SR10070VA-1 >2 x 10^6 IFUs
EUR 906

Sox2 SRR2-pGreenFire Response Reporter, pre-packaged virus

SR20071-VA-1 >2 x 10^6 IFUs
EUR 882

pMIR-Reporter-RASA1(3

PVTB00444-2a 2 ug
EUR 427.2

pMIR-Reporter-IL13(3

PVTB00445-2a 2 ug
EUR 427.2

pLL-CMV-GFP-T2A-Puro [Lenti-LabelerTM virus]

LL100VA-1 >2x10^6 IFUs
EUR 810

pLL-CMV-GFP-T2A-Blast [Lenti-LabelerTM virus]

LL105VA-1 >2x10^6 IFUs
EUR 810

pLL-CMV-RFP-T2A-Puro [Lenti-LabelerTM virus]

LL110VA-1 >2x10^6 IFUs
EUR 810

pLL-CMV-RFP-T2A-Blast [Lenti-LabelerTM virus]

LL115VA-1 >2x10^6 IFUs
EUR 810

pLL-CMV-BFP-T2A-Puro [Lenti-LabelerTM virus]

LL120VA-1 >2x10^6 IFUs
EUR 810

pLL-CMV-BFP-T2A-Blast [Lenti-LabelerTM virus]

LL125VA-1 >2x10^6 IFUs
EUR 810

pLL-CMV-Luciferase-T2A-Puro [Lenti-LabelerTM virus]

LL150VA-1 >2x10^6 IFUs
EUR 810

pLL-EF1a-GFP-T2A-Puro [Lenti-LabelerTM virus]

LL200VA-1 >2x10^6 IFUs
EUR 810

pLL-EF1a-GFP-T2A-Blast [Lenti-LabelerTM virus]

LL205VA-1 >2x10^6 IFUs
EUR 810

pLL-EF1a-RFP-T2A-Puro [Lenti-LabelerTM virus]

LL210VA-1 >2x10^6 IFUs
EUR 810

pLL-EF1a-RFP-T2A-Blast [Lenti-LabelerTM virus]

LL215VA-1 >2x10^6 IFUs
EUR 810

pLL-EF1a-BFP-T2A-Puro [Lenti-LabelerTM virus]

LL220VA-1 >2x10^6 IFUs
EUR 810

pLL-EF1a-BFP-T2A-Blast [Lenti-LabelerTM virus]

LL225VA-1 >2x10^6 IFUs
EUR 810

pLL-EF1a-Luciferase-T2A-Puro [Lenti-LabelerTM virus]

LL250VA-1 >2x10^6 IFUs
EUR 810

pLL-CMV-rFLuc-T2A-GFP [Lenti-LabelerTM virus]

LL300VA-1 >2x10^6 IFUs
EUR 836.4

Lenti-HPV-16 E6/E7 Virus, High Titer

LV617 5 x 20 ul
EUR 1704

Human Alpha-Actin 2, ACTA2 Differentiation Reporter (pGreenZeo, virus)

SR10068VA-1 >2 x 10^6 IFUs
EUR 906

Lenti-CMV-hTERT-GFP-2A-Puro Virus, High Titer

LV624 5 x 20 ul
EUR 2191.2

Lenti-CMV-hTERT-RFP-2A-Puro Virus, High Titer

LV626 5 x 20 ul
EUR 2191.2

Lenti-EF1?¡À-hTERT-Hygro Virus, High Titer

LV632 5 x 20 ul
EUR 2191.2

Pooled Virus Library of all Lenti-miR microRNA Precursor Constructs [4 virus aliquots]

PMIRHPLVA-1 4 virus aliquots
EUR 5974.8

Lentiviral Dual Reporter: CMV-GFP-T2A-Luciferase pre-packaged virus

BLIV101VA-1 >2 x10^6 IFUs
EUR 963.6

Lentiviral Triple Reporter: CMV-Luciferase-RFP-TK pre-packaged virus

BLIV102VA-1 >2 x10^6 IFUs
EUR 963.6

Lentiviral Dual Reporter: UBC-RFP-T2A-Luciferase pre-packaged virus

BLIV200VA-1 >2 x10^6 IFUs
EUR 963.6

Lentiviral Triple Reporter: UBC-Luciferase-RFP-TK pre-packaged virus

BLIV202VA-1 >2 x10^6 IFUs
EUR 963.6

Lentiviral Triple Reporter: MSCV-Luciferase-RFP-TK pre-packaged virus

BLIV302VA-1 >2 x10^6 IFUs
EUR 963.6

BLIV 2.0 Reporter: CMV-Luciferase-EF1a-copGFP Pre-packaged Virus

BLIV511VA-1 >2 x10^6 IFUs
EUR 963.6

Human MLC-2v Differentiation Reporter (pGreenZeo, Virus), EF1-Neo Marker

SR10011VA-N >2 x 10^6 IFUs
EUR 906

pT7- Luc

PVT10670 2 ug
EUR 361.2

pSBE- Luc

PVT10816 2 ug
EUR 361.2

pTRE3G- LUC

PVT10818 2 ug
EUR 361.2

pAP1- Luc

PVT10819 2 ug
EUR 361.2

pHSE- Luc

PVT10820 2 ug
EUR 319.2

pGRE- luc

PVT10821 2 ug
EUR 319.2

pCRE- Luc

PVT10825 2 ug
EUR 361.2

pViperin- Luc

PVT10826 2 ug
EUR 361.2

pTA- Luc

PVT10827 2 ug
EUR 361.2

pTAL- Luc

PVT10829 2 ug
EUR 361.2

pIRF3- Luc

PVT10830 2 ug
EUR 361.2

p53- Luc

PVT10836 2 ug
EUR 319.2

pBV-Luc

PVT12245 2 ug
EUR 843.6

pMR-Luc

PVT14074 2 ug
EUR 843.6

A2ML1 Antibody, HRP conjugated

1-CSB-PA001005LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against A2ML1. Recognizes A2ML1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

A2ML1 Antibody, FITC conjugated

1-CSB-PA001005LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against A2ML1. Recognizes A2ML1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

A2ML1 Antibody, Biotin conjugated

1-CSB-PA001005LD01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against A2ML1. Recognizes A2ML1 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

pCR4-TOPO-A2ML1 vector

PVT12144 2 ug
EUR 369.6

SKOV-3/Luc Cell Line

AKR-232 1 vial
EUR 686.4
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line.

A2ML1 sgRNA CRISPR Lentivector (Human) (Target 3)

K0013804 1.0 ug DNA
EUR 184.8

pLL-CMV-rFLuc-T2A-GFP-mPGK-Puro [Lenti-LabelerTM virus]

LL310VA-1 >2x10^6 IFUs
EUR 836.4

pLL-CMV-rFLuc-T2A-mRFP-mPGK-Puro [Lenti-LabelerTM virus]

LL320VA-1 >2x10^6 IFUs
EUR 836.4

pLL-EF1a-rFLuc-T2A-GFP-mPGK-Puro [Lenti-LabelerTM virus]

LL410VA-1 >2x10^6 IFUs
EUR 836.4

pLL-EF1a-rFLuc-T2A-mRFP-mPGK-Puro [Lenti-LabelerTM virus]

LL420VA-1 >2x10^6 IFUs
EUR 836.4

Sox2 SRR2-pGreenFire Response Reporter (pre-packaged virus, EF1-Puro marker)

SR20071-VA-P >2 x 10^6 IFUs
EUR 882

2C::tdTomato Reporter

PVT10473 2 ug
EUR 319.2

pMIR- Reporter Plasmid

PVT1324 2 ug
EUR 319.2

pGL3 3'UTR reporter WT 1.3 kb CD274 Hs 3'UTR Final Plasmid

PVT17094 2 ug
EUR 390

A2ML1 ELISA Kit (Human) (OKCD01273)

OKCD01273 96 Wells
EUR 950.4
Description: Description of target: Is able to inhibit all four classes of proteinases by a unique 'trapping' mechanism. This protein has a peptide stretch, called the 'bait region' which contains specific cleavage sites for different proteinases. When a proteinase cleaves the bait region, a conformational change is induced in the protein which traps the proteinase. The entrapped enzyme remains active against low molecular weight substrates (activity against high molecular weight substrates is greatly reduced). Following cleavage in the bait region a thioester bond is hydrolyzed and mediates the covalent binding of the protein to the proteinase (By similarity). Displays inhibitory activity against chymotrypsin, papain, thermolysin, subtilisin A and, to a lesser extent, elastase but not trypsin. May play an important role during desquamation by inhibiting extracellular proteases.By similarity;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 0.34 ng/mL

A2ML1 ORF Vector (Human) (pORF)

ORF015134 1.0 ug DNA
EUR 486

a2ML1 ELISA Kit (Human) (OKDD00100)

OKDD00100 96 Wells
EUR 1059.6
Description: Description of target: This gene encodes a member of the alpha-macroglobulin superfamily. The encoded protein is thought to be an N-glycosylated monomeric protein that acts as an inhibitor of several proteases. It has been shown to form covalent interactions with proteases, and has been reported as the p170 antigen recognized by autoantibodies in the autoimmune disease paraneoplastic pemphigus (PNP; PMID:20805888). Mutations in these gene have also been associated with some cases of Noonan syndrome (NS; PMID:24939586) as well as some cases of otitis media (PMID:26121085). Alternative splicing results in multiple transcript variants encoding different isoforms.;Species reactivity: Human;Application: ;Assay info: Quantitative Sandwich ELISA;Sensitivity: < 0.067 ng/mL

pUC57-Tac-Luc

PVT18215 2 ug
EUR 309.6

p21-Luc Plasmid

PVTB00035-2c 2 ug
EUR 427.2

IgK- IFN- luc

PVT10425 2 ug
EUR 319.2

pNFAT- TA- Luc

PVT10808 2 ug
EUR 319.2

pE2F- TA- Luc

PVT10809 2 ug
EUR 319.2

pISRE- TA- Luc

PVT10810 2 ug
EUR 319.2

pGAS- TA- Luc

PVT10811 2 ug
EUR 319.2

pP53- TA- luc

PVT10814 2 ug
EUR 361.2

pStat3- TA- luc

PVT10815 2 ug
EUR 361.2

pHes1 (2.5k)- Luc

PVT10832 2 ug
EUR 319.2

pHes1 (467)- luc

PVT10833 2 ug
EUR 319.2

pNF-kB-Luc

PVT1322 2 ug
EUR 390

pGL3-ELAM-Luc

PVT14533 2 ug
EUR 718.8

proE-cad178-Luc

PVT14614 2 ug
EUR 718.8

pSynSRE-T-Luc

PVT14626 2 ug
EUR 843.6

BLIV 2.0 Reporter: MSCV-Luciferase-EF1a-copGFP-T2A-Puro Pre-packaged Virus

BLIV713VA-1 >2 x10^6 IFUs
EUR 963.6

pGreenFire 2.0 NFAT reporter virus (pGF2-NFAT-rFluc-T2A-GFP-mPGK-Puro)

TR451VA-P >2 x 10^6 IFUs
EUR 920.4

β-Lactamase (Luciferase) lentiviral particles

LVP335-luc 1x107 IFU/ml x 200ul
EUR 418.8
Description: pre-made lentiviral particles expressing β-Lactamase gene. A firefly luciferase marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

A549 / Luciferase (Puromycin) stable cell line

SC043-Luc 2 x 106 cell/ml x 1ml
EUR 1104
Description: Luciferase (firefry) expression stable cell line in A549 human cancer cell line with Puromycin marker.

Human AsPC1 / Luciferase Cell Line

SC062-Luc 2 x 106 cell/ml x 1ml
EUR 1800
Description: Firefly luciferase expression stable cell line in Human AsPC1 cells with Puromycin resistance

mouse MOPC315 / Luciferase Cell Line

SC063-Luc 2 x 106 cell/ml x 1ml
EUR 2670
Description: Firefly luciferase expression stable cell line in mouse MOPC315 cells with Puromycin resistance

Huamn SW403 / Luciferase Stable Cells

SC067-Luc 2 x 106 cell/ml x 1ml
EUR 1800
Description: Firefly luciferase expression stable cell line in human SW403 cells with Puromycin resistance

Human PANC-1 / Luciferase (Puro) Cell Line

SC068-Luc 2 x 106 cell/ml x 1ml
EUR 2670
Description: Firefly luciferase expression stable cell line in Human PANC-1 cells with Puromycin resistance

lenti- sgRNA- TagRFP- uspzz- 3 Plasmid

PVT7232 2 ug
EUR 319.2

Lenti-SV40 Lentivirus

G203 10 ml
EUR 973.2

Lenti-SV40T Lentivirus

G256 10 ml
EUR 882

Lenti-SV40Tt Lentivirus

G258 10 ml
EUR 882

Lenti- Cas9- Puro

PVT10981 2 ug
EUR 319.2

Virus Parainfluenza Virus 3 (HPIV-3) Protein

abx670267-1ml 1 ml
EUR 710.4

Luciferase Reporter Assay Kit

55R-1540 200 assays
EUR 294
Description: Assay Kit for detection of Luciferase Reporter in the research laboratory

Luciferase Reporter Assay Kit

K801-200
EUR 235.2

Luciferase Reporter Assay Kit

K2181-200 200 assays
EUR 217.2

TFEB promoter-luciferase reporter

PVT18227 2 ug
EUR 360

pGreenFire 2.0 NFkB reporter virus (pGF2-NF?B-rFluc-T2A-GFP-mPGK-Puro)

TR412VA-P >2 x 10^6 IFUs
EUR 920.4

pGreenFire 2.0 HIF-1 reporter virus (pGF2-HIF1-rFluc-T2A-GFP-mPGK-Puro)

TR426VA-P >2 x 10^6 IFUs
EUR 920.4

pGreenFire 2.0 AP-1 reporter virus (pGF2-AP1-rFluc-T2A-GFP-mPGK-Puro)

TR452VA-P >2 x 10^6 IFUs
EUR 920.4

Recombinant Transmembrane Protease Serine 2 Protein, Partial

E80016
  • EUR 470.80
  • EUR 753.50
  • EUR 1824.90
  • 20 ul
  • 100 ul
  • 500 ul

Fisher’s exact and paired sample t-tests were conducted to evaluate the difference between continuous and categorical variables, respectively. Valid for reactivation implantation post-LVAD counted in cases, and implantation of the appropriate time post-LVAD determined in control patients for comparisonsDays variable reactivation of implantation post-LVAD counted in cases, and implantation of the appropriate time post-LVAD determined in patients controls for comparison variables.

Leave A Comment